Cargando…

Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors

Infections represent a significant cause of morbidity and mortality in cancer patients. Multiple factors related to the patient, tumor, and cancer therapy can affect the risk of infection in patients with solid tumors. A thorough understanding of such factors can aid in the identification of patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubeček, Ondřej, Paterová, Pavla, Novosadová, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705721/ https://www.ncbi.nlm.nih.gov/pubmed/34947918 http://dx.doi.org/10.3390/life11121387

Ejemplares similares

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes
por: Sojka, Ladislav, et al.
Publicado: (2022)

Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové
por: Vaverková, Kristýna, et al.
Publicado: (2021)

Bloodstream Infections in Patients With Solid Tumors: Epidemiology, Antibiotic Therapy, and Outcomes in 528 Episodes in a Single Cancer Center
por: Marín, Mar, et al.
Publicado: (2014)

Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa
por: Zavrelova, Alzbeta, et al.
Publicado: (2023)

Combined Therapy of Locally Advanced Oesophageal and Gastro–Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors
por: Vošmik, Milan, et al.
Publicado: (2021)

Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia
por: Ramachandran, Shaliny, et al.
Publicado: (2015)

Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents
por: Zitko, Jan, et al.
Publicado: (2018)

Risk Factors of Initial Inappropriate Antibiotic Therapy and the Impacts on Outcomes of Neonates with Gram-Negative Bacteremia
por: Chu, Shih-Ming, et al.
Publicado: (2020)

Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation
por: Jandourek, Ondrej, et al.
Publicado: (2017)

Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors
por: Bouz, Ghada, et al.
Publicado: (2017)

198. Clinical Prediction of Bacteremia and the Need for Early Antibiotic Therapy in Solid Tumor Cancer Patients
por: Hyak, Jonathan M, et al.
Publicado: (2020)

1232 Antibiotic Stewardship for Urinary Tract Infections (UTI): Impact on Therapy and Clinical Outcomes
por: Gill, Veenu, et al.
Publicado: (2014)

The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review
por: Kubeček, Ondřej, et al.
Publicado: (2017)

Impact of the adequacy of antibiotic therapy on the outcome of ventilator-associated pneumonia
por: Goncalves-Pereira, J, et al.
Publicado: (2011)

Solid Tumor Differentiation Therapy – Is It Possible?
por: Dela Cruz, Filemon, et al.
Publicado: (2012)

Onivyde for the therapy of multiple solid tumors
por: Zhang, Haijun
Publicado: (2016)

Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales
por: Dunne, Michael W., et al.
Publicado: (2022)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

N-Substituted 5-Amino-6-methylpyrazine-2,3-dicarbonitriles: Microwave-Assisted Synthesis and Biological Properties
por: Jandourek, Ondrej, et al.
Publicado: (2014)

New Potentially Active Pyrazinamide Derivatives Synthesized Under Microwave Conditions
por: Jandourek, Ondrej, et al.
Publicado: (2014)

Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity
por: Pallabothula, Vinod Sukanth Kumar, et al.
Publicado: (2022)

Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis
por: Duncan, Christopher J. A., et al.
Publicado: (2013)

Impact of empiric antibiotic therapy on the clinical outcome of acute calculous cholecystitis
por: de Miguel-Palacio, Maite, et al.
Publicado: (2023)

1431. Comparison of Treatment Outcomes with Definitive Antibiotic Therapy and Empiric Antibiotic Therapy in Osteomyelitis
por: Holzum, Dorothy, et al.
Publicado: (2019)

Potential of epigenetic therapies in the management of solid tumors
por: Valdespino, Victor, et al.
Publicado: (2015)

HDAC/IKK inhibition therapies in solid tumors
por: Vancurova, Ivana, et al.
Publicado: (2017)

Use of Antiangiogenic Therapies in Pediatric Solid Tumors
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Barriers to antibody therapy in solid tumors, and their solutions
por: Matsumura, Yasuhiro
Publicado: (2021)

Engaging plasticity: Differentiation therapy in solid tumors
por: Bar-Hai, Neta, et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

Clinical Trials of Cellular Therapies in Solid Tumors
por: Secondino, Simona, et al.
Publicado: (2023)

Adequacy of Empiric Antibiotics Therapy and Its Impact on Outcomes in Adult Critically Ill Sepsis Patients: A Review
por: Al-Ani, Ahmad Habeeb Hattab Dala Ali, et al.
Publicado: (2022)

Volumetric modulated arc therapy for treatment of solid tumors: current insights
por: Macchia, Gabriella, et al.
Publicado: (2017)

5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
por: Ambrożkiewicz, Weronika, et al.
Publicado: (2020)

Risk of infection associated with targeted therapies for solid organ and hematological malignancies
por: Ruiz-Camps, Isabel, et al.
Publicado: (2021)

Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies
por: Bouz, Ghada, et al.
Publicado: (2019)

Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection
por: Ghuneim, Lydia-Ann J., et al.
Publicado: (2022)

Risk of Bacterial, Viral, and Fungal Infections in Patients With Solid Malignant Tumors Treated With Curative Intent Radiation Therapy
por: Terrones-Campos, Cynthia, et al.
Publicado: (2022)

3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation
por: Semelková, Lucia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j436f8t2r3o8dgsel3cpqgvu8p